Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Inclusion Criteria: * Meet the diagnostic criteria for immune thrombocytopenia; * Untreated hospitalized patients, may be male or female, between the ages of 18\~ 80 years; * To show a platelet count \<30 \* 10\^9/L, and with bleeding manifestations; * Willing and able to sign written informed consent Exclusion Criteria: * Received chemotherapy or anticoagulants or other drugs affecting the platelet counts within 3 months before the screening visit; * Received second-line ITP-specific treatments (eg, cyclophosphamide, 6-mercaptopurine, vincristine, vinblastine, etc) within 3 months before the screening visit; * Received high-dose steroids or IVIG in the 3 weeks prior to the start of the study; * Current HIV infection; * Severe medical condition (lung, hepatic or renal disorder) other than chronic ITP. Unstable or uncontrolled disease or condition related to or impacting cardiac * Female patients who are nursing or pregnant, who may be pregnant, or who contemplate pregnancy during the study period; * Have a known diagnosis of other autoimmune diseases, established in the medical history and laboratory findings with positive results for the determination of antinuclear antibodies, anti-cardiolipin antibodies, lupus anticoagulant or direct Coombs test; * Patients who are deemed unsuitable for the study by the investigator.